Trials / Unknown
UnknownNCT03480308
Effect of Addition of Fentanyl or Dexamethasone or Both to Bupivacaine in Paravertebral Block for Patients Undergoing Major Breast Surgery
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 1 (estimated)
- Sponsor
- Assiut University · Academic / Other
- Sex
- Female
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
This study evaluated the analgesic efficacy of fentanyl and dexamethasone in combination with bupivacaine for single-shot paravertebral block (PVB) in patients undergoing major breast surgery.
Detailed description
This study evaluated the analgesic efficacy of fentanyl and dexamethasone in combination with bupivacaine for single-shot paravertebral block (PVB) in patients undergoing major breast surgery. Patients will receive ultrasound guided paravertebral block and stratified into 3 groups according to medication used : Group 1 : bupivacaine (0.5%) 20 ml , fentanyl 1 μg/kg Group 2 : bupivacaine (0.5%) 20 ml , dexamethasone 4 mg Group 2 : bupivacaine (0.5%) 20 ml , fentanyl 1 μg/kg , dexamethasone 4 mg
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Fentanyl | Patients will receive bupivacaine (0.5%) 20 ml , fentanyl 1 μg/kg in paravertebral block |
| DRUG | Dexamethasone | Patients will receive bupivacaine (0.5%) 20 ml , Dexamethasone 4mg in paravertebral block |
| DRUG | Bupivacaine | Bupivacaine |
Timeline
- Start date
- 2018-04-01
- Primary completion
- 2019-04-01
- Completion
- 2021-03-30
- First posted
- 2018-03-29
- Last updated
- 2021-02-23
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT03480308. Inclusion in this directory is not an endorsement.